Chronic Disease Management Flashcards
7 cards from real MTM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Chronic Disease Management flashcards as text
A patient with type 2 diabetes has an HbA1c of 9.2% despite metformin 1000 mg twice daily. Which is the most appropriate next step in therapy?
Answer: Add a GLP-1 receptor agonist or SGLT-2 inhibitor with cardiovascular benefit if indicated
Current ADA guidelines recommend adding agents with proven cardiovascular or renal benefit (GLP-1 RA or SGLT-2i) as preferred second-line therapy when HbA1c remains above goal.
Which blood pressure target is recommended for most patients with hypertension and established cardiovascular disease according to current guidelines?
Answer: Less than 130/80 mmHg
The AHA/ACC 2017 guidelines recommend a BP target of <130/80 mmHg for patients with hypertension and established CVD.
A COPD patient uses a short-acting beta-agonist (SABA) more than twice per week for symptom relief. According to GOLD guidelines, this indicates:
Answer: Inadequately controlled symptoms requiring therapy escalation
Frequent rescue inhaler use (>2 days/week) signals uncontrolled symptoms and warrants reassessment and escalation of maintenance therapy per GOLD guidelines.
Which monitoring parameter is MOST critical when initiating an ACE inhibitor in a patient with chronic kidney disease?
Answer: Serum creatinine and potassium within 1–2 weeks
ACE inhibitors can cause acute rises in creatinine and hyperkalemia in CKD patients, so renal function and electrolytes must be rechecked within 1–2 weeks of initiation.
A patient with heart failure with reduced ejection fraction (HFrEF) is on optimal medical therapy. Which medication class has demonstrated mortality reduction in this population?
Answer: Beta-blockers (carvedilol, metoprolol succinate, or bisoprolol)
Evidence-based beta-blockers (carvedilol, metoprolol succinate, bisoprolol) are proven to reduce mortality in HFrEF and are part of the guideline-directed medical therapy quartet.
In a patient with asthma, a written asthma action plan should be based primarily on:
Answer: Symptom monitoring and/or peak flow measurements
NAEPP guidelines recommend that asthma action plans be guided by symptom assessment and/or peak expiratory flow monitoring to allow patients to self-manage exacerbations.
Which lipid-lowering strategy is recommended for a 55-year-old patient with type 2 diabetes and a 10-year ASCVD risk of 14%?
Answer: High-intensity statin therapy
ACC/AHA guidelines recommend high-intensity statin therapy for diabetic patients aged 40–75 with a 10-year ASCVD risk ≥7.5%.